The hepatic steatosis index (HSI) utilizes AST/ALT ratio, body mass index (BMI), diabetes status, and gender to determine a predictive value for NAFLD/NASH. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.